Phil Shugart, President of Carolina Liquid Chemicals, introduces VP Joe Biden

October 8, 2021

Originally published June 6, 2012. Vice President Joe Biden spoke Wednesday at Wake Forest Biotech Place in Winston-Salem, encouraging scientific research and highlighting the type of job creation needed in a changing economy. Biden spoke... Read more »

Medline to Offer First Ever FDA-Cleared, Point-of-Care Fentanyl Urine Screening Kit on RYAN™ Analyzer

August 2, 2024

GREENSBORO, NC — (July 31, 2024) — Carolina Liquid Chemistries Corp. (CLC) has entered into a distribution agreement with Medline Industries, LP (Medline) to make the first ever FDA-cleared, point-of-care fentanyl screening test kit readily... Read more »

Carolina Liquid Chemistries Now Offers K-ASSAY® CLIA Moderate Complexity Microalbumin Reagent for Use on the Medica EasyRA® Benchtop Clinical Chemistry Analyzer

November 30, 2023

GREENSBORO, NC — (November 30, 2023) – Carolina Liquid Chemistries Corp. (CLC) has partnered with Kamiya Biomedical Company (Kamiya) to obtain CLIA1 moderate complexity categorization for K-ASSAY® Microalbumin reagent for use on the Medica EasyRA®... Read more »

CLC Newsletter – Nov 2023

November 8, 2023

Drug Screening Assays Now Available on the Diazyme DZ-Lite™ c270 Benchtop Clinical Chemistry Analyzer

September 6, 2023

Making It One of the Most Versatile Analyzers on the Market with an Extensive Test Menu Including General Chemistries, Special Chemistries, and Drug Tests GREENSBORO, NC — (September 6, 2023) – Carolina Liquid Chemistries Corp.... Read more »

The Mission of Our Newsletter

July 7, 2023

First Ever Point-of-Care Instrument to Test for Fentanyl Receives FDA Clearance

March 8, 2023

Greensboro, NC (March 8, 2023) – Shenzhen Superbio Technology Co., LTD. (Superbio) has received clearance from the US Food and Drug Administration (FDA) on the first ever point-of-care instrument intended for qualitative detection of fentanyl in... Read more »

Carolina Liquid Chemistries Wins Summary Judgment, Defeating False Claim Act Allegation

February 1, 2023

GREENSBORO, NC — (Feb. 1, 2023) – Carolina Liquid Chemistries Corp. (CLC) won a major victory securing summary judgment in a high-value, long-running False Claims Act case in the Northern District of California in which... Read more »

Carolina Liquid Chemistries Corp. and Diazyme Laboratories, Inc. Announce Partnership Expanding Test Menu on the Diazyme DZ-Lite™ c270 Benchtop Clinical Chemistry Analyzer, Adding 25 New Assays Totaling Over 45 CLIA Categorized Assays

January 20, 2023

GREENSBORO, NC — (Jan. 20, 2023) – Carolina Liquid Chemistries Corp. (CLC) and Diazyme Laboratories, Inc. (Diazyme) announce a partnership to expand the test menu on the Diazyme DZ-Lite™ c270 benchtop clinical chemistry analyzer. Diazyme,... Read more »

Carolina Liquid Chemistries Corp. Helps to Alleviate Supply Chain Issues by Offering Photometric Electrolyte Test Kits

April 27, 2022

Greensboro, NC (April 15, 2022) – Carolina Liquid Chemistries Corp. now offers photometric chloride, potassium, and sodium electrolyte blood test kits for use on the CLC Family of clinical chemistry analyzers: the CLC6410, CLC1600, and... Read more »

Carolina Liquid Chemistries Corp.’s Brea, CA Production Facility Honored by Spectrum Chemical Mfg. Corp.

April 15, 2022

Greensboro, NC (March 22, 2022) – Spectrum Chemical Mfg. Corp. (Spectrum Chemical), a leading global provider of fine chemicals, lab equipment, and supplies serving more than 120 industries, has selected Carolina Liquid Chemistries Corp. (CLC)... Read more »